cbdMD (YCBD) Other Non-Current Assets (2016 - 2026)
cbdMD (YCBD) posted Other Non-Current Assets of $62708.0 for Q4 2025, little changed sequentially from $62708.0 in Q3 2025, and down 98.79% YoY from $5.2 million in Q4 2024.
cbdMD (YCBD) Other Non-Current Assets (2016 - 2026) Analysis & Trends
cbdMD has reported Other Non-Current Assets for 10 years, with the latest figure at $62708.0 in Q4 2025.
- Quarterly Other Non-Current Assets fell 98.79% year-over-year to $62708.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $62708.0 (down 98.79% YoY) and the FY2025 annual result came in at $62708.0, down 98.5% from the prior year.
- Other Non-Current Assets steadied at $62708.0 in Q4 2025 per YCBD's latest filing, from $62708.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $88.4 million in Q3 2021 and troughed at $62708.0 in Q1 2025.
- A 5-year average of $9.1 million and a median of $191657.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets sank 99.8% in 2022, then soared 4625.25% in 2024.
- Over 5 years, Other Non-Current Assets stood at $69.6 million in 2021, then tumbled by 99.8% to $138708.0 in 2022, then fell by 4.69% to $132203.0 in 2023, then jumped by 3819.94% to $5.2 million in 2024, then sank by 98.79% to $62708.0 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $62708.0, $62708.0, and $4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 5.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.45 Mn |
| Dec 31, 2025 | 62,708.00 |
| Sep 30, 2025 | 62,708.00 |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 62,708.00 |
| Dec 31, 2024 | 5.18 Mn |
| Sep 30, 2024 | 4.19 Mn |
| Jun 30, 2024 | 6.55 Mn |
| Mar 31, 2024 | 132,203.00 |
| Dec 31, 2023 | 132,203.00 |
| Sep 30, 2023 | 138,708.00 |
| Jun 30, 2023 | 138,708.00 |
| Mar 31, 2023 | 138,708.00 |
| Dec 31, 2022 | 138,708.00 |
| Sep 30, 2022 | 244,606.00 |
| Jun 30, 2022 | 244,606.00 |
| Mar 31, 2022 | 138,708.00 |
| Dec 31, 2021 | 69.65 Mn |
| Sep 30, 2021 | 88.38 Mn |
| Jun 30, 2021 | 529,583.00 |